PMID: 11898257Mar 20, 2002Paper

Attitudes toward genetic testing in patients with colorectal cancer

Cancer Practice
Anita Yeomans KinneyR S Sandler

Abstract

The purpose of this study was to examine risk perceptions and interest in genetic testing among African American and White patients with colorectal cancer. In this cross-sectional study, 98 patients with colorectal cancer participated in a brief structured telephone interview. Information was collected on knowledge and risk perceptions regarding colorectal cancer genetics, health behaviors, knowledge about the availability of genetic testing, and interest in genetic testing for colorectal cancer susceptibility. Sixty-one percent of the participants were worried about their relatives' risk of colorectal cancer, and 64% were concerned about being a colorectal cancer susceptibility gene carrier. Although 81% of the participants reported that they had never heard about a genetic test for colorectal cancer susceptibility, 72% stated that they would want to take the test if it were available. Predictors of intention to have a genetic test were younger age, less advanced stage of disease, and more frequent thoughts about colorectal cancer being hereditary. These results suggest that the demand for genetic testing may be great, despite a general lack of knowledge about colorectal cancer genetics and the potential risks and limitations ...Continue Reading

References

Apr 15, 1991·Annals of Internal Medicine·C LermanP F Engstrom
Jan 1, 1989·American Journal of Epidemiology·R M Mickey, S Greenland
Oct 1, 1995·American Journal of Public Health·K R Smith, R T Croyle
Jan 1, 1995·Annual Review of Medicine·R W BurtL Cannon-Albright
Feb 15, 1995·Journal of the National Cancer Institute·C LermanA Balshem
Sep 15, 1994·American Journal of Medical Genetics·A M CodoriJ Brandt
Nov 2, 1994·Journal of the National Cancer Institute·M L Slattery, R A Kerber
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LermanA Balshem
Feb 20, 1996·International Journal of Cancer. Journal International Du Cancer·C LermanA Gomez-Caminero
Jun 26, 1996·JAMA : the Journal of the American Medical Association·C LermanH Lynch
Jan 15, 1997·Journal of the National Cancer Institute·C LermanM M Reed
May 14, 1997·JAMA : the Journal of the American Medical Association·G GellerM J Kahn
Jun 1, 1997·Journal of Consulting and Clinical Psychology·C LermanH T Lynch
Sep 1, 1997·Nature Genetics·S J LakenB Vogelstein
Jan 23, 1998·Current Problems in Cancer·R GryfeJ Couture
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LermanH T Lynch
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G GellerN A Holtzman
Oct 2, 1998·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·M D SchwartzV Vogel
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L G BlumanE P Winer
Mar 26, 1999·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·K FaddenR W Owen
May 11, 1999·JAMA : the Journal of the American Medical Association·C LermanH T Lynch
Jun 16, 1999·Nature Genetics·B Bowles Biesecker, T M Marteau
Jul 1, 1999·The New England Journal of Medicine·F S Collins
Nov 5, 1999·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J G McVie
Dec 11, 2002·AACN Clinical Issues·Jean Jenkins

❮ Previous
Next ❯

Citations

Aug 21, 2010·Genetic Testing and Molecular Biomarkers·Susan T VadaparampilDavid Shibata
Jan 10, 2012·Genetic Testing and Molecular Biomarkers·Deborah CragunSusan T Vadaparampil
Apr 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Julie N HarrisJanet L Stanford
Feb 13, 2004·Research and Theory for Nursing Practice·Hilary D SigmonPatricia A Grady
May 3, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Michael J HallMary B Daly
May 6, 2009·Best Practice & Research. Clinical Gastroenterology·Victoria M Raymond, Jessica N Everett
Jun 27, 2009·Cancer Control : Journal of the Moffitt Cancer Center·Anjali D DeshpandeMatthew W Kreuter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Genetic Testing and Molecular Biomarkers
Susan T VadaparampilDavid Shibata
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Michael J HallNeal J Meropol
Genetics in Medicine : Official Journal of the American College of Medical Genetics
June A PetersMark H Greene
© 2022 Meta ULC. All rights reserved